Global Health Innovative Technology Fund

CIT GAP Funds Invests in EstateTech Company OneDigitalTrust to Support Reinventing Personal Estate Planning for the Digital Age

Retrieved on: 
Monday, November 1, 2021
Alpha Natural Resources, Washington, Entrepreneurship, VIPA, Acceleration, DIY, Trust, Authority, New Enterprise Associates, Dwight Schrute, Family, IAB, General Electric, Insurance, CIT, Platform, Platform as a service, Center, Commonwealth, Marketing, Johnson & Johnson, Organic, Investment, Global Health Innovative Technology Fund, CEO, Movement, Growth, Opportunity zone, Solution, GLOBE, Financial services, Management

OneDigitalTrust will use the funding from CIT GAP Funds to enhance its platforms capabilities and expand its business development, marketing and customer capture programs.

Key Points: 
  • OneDigitalTrust will use the funding from CIT GAP Funds to enhance its platforms capabilities and expand its business development, marketing and customer capture programs.
  • OneDigitalTrust recognizes that an estate plan is among the most personal of documents, containing often highly emotional and detailed decisions about family and finances.
  • We are grateful for the support of CIT GAP Funds and look forward to expanding our customer base.
  • CIT GAP Funds' investment decisions are guided by the CIT GAP Funds Investment Advisory Board (IAB).

Amine Nedjai appointed CEO of Alpha Blue Ocean family-office

Retrieved on: 
Monday, October 25, 2021
Consulting, Banking, Professional Services, Finance, Translation, Method, Contract, Innovation, CIO, PIPES, Investment, Senior, Private investment in public equity, ABO, Interview, CEO, DBT, Multimedia, COO, Global Health Innovative Technology Fund, Health, Solution, Bloomberg, Overseas Private Investment Corporation, Science, Hugo, Amaury, Bloomberg L.P., Management, Asphalt, Renewable energy

This objective of this change is to foster a new phase of development for Alpha Blue Ocean group.

Key Points: 
  • This objective of this change is to foster a new phase of development for Alpha Blue Ocean group.
  • View the full release here: https://www.businesswire.com/news/home/20211024005055/en/
    Amine Nedjai, CEO Alpha Blue Ocean (Photo: Alpha Blue Ocean)
    Amine Nedjai started his career at Bloomberg LP.
  • Pierre Vannineuse, Founder of Alpha Blue Ocean : "Amine has been with us since the very beginning.
  • Amine Nedjai, CEO of Alpha Blue Ocean : "I am truly grateful to Pierre.

QIAGEN Strengthens UK Footprint With Move to New Manchester Facilities

Retrieved on: 
Friday, October 22, 2021
Biotechnology, Genetics, Health, Clinical Trials, EGFR, Breast cancer, PIK3CA, Biotechnology, Diagnosis, Blood, PCR, Budget, Disease, Health Innovation Manchester, Genomics, Colorectal cancer, NGS, BRAF, Patient, Transport, FDA, FGFR, Large-cell lung carcinoma, List of life sciences, Weather, RNA, Molecular diagnostics, U.S. Securities and Exchange Commission, Life, Senior, Annual report, CityLab, Marketing, Protein, Central business district, COVID-19, Growth, Precision medicine, Polymerase chain reaction, Solution, Health, Knowledge, Lists of disasters, Automation, Heart, Squamous cell carcinoma, George C. Marshall European Center for Security Studies, Global Health Innovative Technology Fund, KRAS, DNA, Pharmaceutical industry, Warehouse

QIAGEN today announced the completion of the move of its European Center of Excellence for Precision Medicine into facilities in Manchesters CityLabs 2.0, a new genomics campus developed with Health Innovation Manchester.

Key Points: 
  • QIAGEN today announced the completion of the move of its European Center of Excellence for Precision Medicine into facilities in Manchesters CityLabs 2.0, a new genomics campus developed with Health Innovation Manchester.
  • The move into the new facility will help us write the next chapter of this success story.
  • Health Innovation Manchester unites the regions spectrum of public, academic and clinical resources.
  • It is meant to bring the benefits of transformational molecular diagnostics to Manchester and the global healthcare market.

Allison+Partners Bolsters Health Practice with Several Hires and Client Wins

Retrieved on: 
Wednesday, October 20, 2021
Other Communications, Public Relations, Investor Relations, Marketing, Communications, Professional Services, Health, General Health, Other Professional Services, Blogging, BCW, Natoli, Corporation, Technology, PRWeek, Weber Shandwick, Genetic testing, Growth, Health equity, Creativity, Multimedia, Vedas, Public affairs, Burson Cohn & Wolfe, Research, Mark Penn, Global Health Innovative Technology Fund, Leadership, The Best Place to Be, Consumer Brands Association, Health, Marketing, Fertility, Management

Notable health client wins include Nordic Consulting , Perspectum , Talis Biomedical and veda.

Key Points: 
  • Notable health client wins include Nordic Consulting , Perspectum , Talis Biomedical and veda.
  • She will serve as the senior lead for the agencys growing health tech portfolio and several of the agencys new clients.
  • She also serves as the lead for the agencys health equity client offering.
  • In addition to the senior team, new hires for the health practice in 2021 include Maddie Wojtalewicz, Julia Palomino, Elizabeth Osunkwo and Lucy Neubeck.

Boehringer Ingelheim and Partners to Accelerate Development of First-In-Class Gene Therapy for Patients with Cystic Fibrosis

Retrieved on: 
Tuesday, October 19, 2021
Biotechnology, General Health, Health, Genetics, Pharmaceutical, University, Doctor of Philosophy, Cystic fibrosis, Cell, GTC, Discovery, News, Organization, CFTR, National Institute for Health Research, Achievement, Lung, OXB, Â, Oxford BioMedica, Trust, Department, Cystic Fibrosis Trust, Department of Health and Social Care, Exercise, Research, Social work, Intellectual property, Medical research, Degenerative disease, Leadership, National Institute, Knowledge, Children's Medical Research Institute, Patient, Wellcome, Imperial College London, CF, Dysfunction, Department of Zoology, University of Oxford, Partnership, Infection, Efficiency, IP Group, Boehringer Ingelheim, Global Health Innovative Technology Fund, Pharmaceutical industry

The GTC is additionally contributing its knowledge in pre-clinical research and clinical gene therapy development.

Key Points: 
  • The GTC is additionally contributing its knowledge in pre-clinical research and clinical gene therapy development.
  • OXB is adding its leading competence in manufacturing lentiviral vector-based therapies to Boehringer Ingelheims expertise in the development of novel breakthrough therapies for respiratory diseases.
  • This partnership is central to our companys mission of delivering life changing gene therapies to patients and has the potential to provide a new therapeutic option for many cystic fibrosis patients globally.
  • David Ramsden, Chief Executive of the Cystic Fibrosis Trust said: It is great news that Boehringer Ingelheim have committed to the next stage of the development of a gene therapy treatment for people with cystic fibrosis.

CIT GAP Funds Invests in BCMstrategy to Bring the Data Revolution to Policy Intelligence

Retrieved on: 
Monday, October 18, 2021
Leadership, Dwight Schrute, Noise, Technology, Acceleration, Center, SharePoint, Dow Jones, Opportunity zone, Social media, Awareness, Global Health Innovative Technology Fund, Risk, Growth, Alpha Natural Resources, CIT, Public policy, Bloomberg Terminal, Policy, Traction, Johnson & Johnson, Commonwealth, Bloomberg, General Electric, VIPA, Authority, GLOBE, Investment, IAB, API, CEO, Entrepreneurship, Data, Partnership, FTP, New Enterprise Associates, Renewable energy, Management

Richmond, VA, Oct. 18, 2021 (GLOBE NEWSWIRE) -- The Center for Innovative Technology ( CIT ) today announced that CIT GAP Funds has invested in Alexandria, Va.-based BCMstrategy .

Key Points: 
  • Richmond, VA, Oct. 18, 2021 (GLOBE NEWSWIRE) -- The Center for Innovative Technology ( CIT ) today announced that CIT GAP Funds has invested in Alexandria, Va.-based BCMstrategy .
  • BCMstrategy uses patented, cutting-edge technology to deliver objective, structured policy momentum data to sophisticated capital markets participants that will help them make better decisions.
  • We are grateful for the support of CIT GAP Funds and look forward to continuing our growth in the financial market!
  • CIT GAP Funds' investment decisions are guided by the CIT GAP Funds Investment Advisory Board (IAB).

CIT GAP Funds Invests in Cerillo to Illuminate Scientific Research Possibilities with Innovative Technologies

Retrieved on: 
Wednesday, October 13, 2021
Transfer, Leadership, CRCF, Dwight Schrute, Government, Acceleration, Technology, Center, Program, Small Business Innovation Research, Opportunity zone, Industry, LinkedIn, Global Health Innovative Technology Fund, Incubator, Growth, Alpha Natural Resources, CIT, Global Universities Partnership on Environment and Sustainability, CCF, Marketing, Johnson & Johnson, Commonwealth, VIPA, General Electric, Data collection, Authority, Investment, SBIR, GLOBE, IAB, CEO, Entrepreneurship, Twitter, STTR, New Enterprise Associates, Management

Cerillo designs innovative laboratory technologies that allow scientists to collect data more efficiently and researchers to amplify their impact on the world.

Key Points: 
  • Cerillo designs innovative laboratory technologies that allow scientists to collect data more efficiently and researchers to amplify their impact on the world.
  • Cerillo is illuminating the possibilities within scientific research for our customers across the globe, and Im proud to be a part of it.
  • We are excited to have the support of CIT GAP Funds and look forward to our next phase of growth.
  • CIT GAP Funds' investment decisions are guided by the CIT GAP Funds Investment Advisory Board (IAB).

CIT GAP Funds Invests in Impruvon to Help Prevent Dangerous Medication Errors

Retrieved on: 
Thursday, September 30, 2021
Transfer, Regulation of tobacco by the U.S. Food and Drug Administration, Food, SBIR, Compliance, Diagnosis, Alpha Natural Resources, Dwight Schrute, General Electric, Health, Veteran, FDA, Small Business Innovation Research, Patient, Approximation error, Theft, LinkedIn, Entrepreneurship, Marketing, CRCF, Opportunity zone, Twitter, New Enterprise Associates, CEO, Program, Center, Growth, Awareness, CIT, IAB, Technology, Johnson & Johnson, VIPA, Commonwealth, Global Universities Partnership on Environment and Sustainability, Global Health Innovative Technology Fund, STTR, Investment, Acceleration, CCF, COO, Industry, Education, Authority, GLOBE, Medical device, Pharmaceutical industry

In addition to medication errors, common problems include theft or misuse of medication doses, and general lack of medication compliance such as missed doses.

Key Points: 
  • In addition to medication errors, common problems include theft or misuse of medication doses, and general lack of medication compliance such as missed doses.
  • Having experienced the detrimental impacts that medication errors can have on individuals and their families first hand, our team has a unique understanding of our customers.
  • We are thrilled to have the support of CIT GAP Funds and look forward to our next phase of growth.
  • CIT GAP Funds' investment decisions are guided by the CIT GAP Funds Investment Advisory Board (IAB).

CIT GAP Funds Virginia Founders Fund Invests in Aravenda to Advance the Future of Resale Technology

Retrieved on: 
Wednesday, September 29, 2021
Transfer, Social media, Goal, E-commerce, INTO University Partnerships, SBIR, Alpha Natural Resources, Dwight Schrute, General Electric, Board of directors, Small Business Innovation Research, Â, LinkedIn, Entrepreneurship, Board, Shoe, Director, CRCF, Opportunity zone, Twitter, New Enterprise Associates, CEO, Program, Life, Center, Growth, Female, CIT, IAB, Technology, VIPA, Commonwealth, Tradesy, Johnson & Johnson, Maintenance, Creativity, Global Health Innovative Technology Fund, Color, VFF, Economic development, STTR, Investment, Acceleration, CCF, Time, Industry, Authority, GLOBE, Cryptocurrency, Online shopping

Most resale technology today lacks cloud-based capabilities and customer service platforms to expand business to a wide online audience.

Key Points: 
  • Most resale technology today lacks cloud-based capabilities and customer service platforms to expand business to a wide online audience.
  • We are excited to have the support of CIT GAP Funds and look forward to our next phase of growth.
  • CIT GAP Funds' investment decisions are guided by the CIT GAP Funds Investment Advisory Board (IAB).
  • Programs include | CIT GAP Funds | Commonwealth Research Commercialization Fund (CRCF) | Commonwealth Commercialization Fund (CCF) | Virginia Founders Fund | Smart Communities | Cybersecurity | Unmanned Systems | SBIR/STTR Support (Small Business Innovation Research (SBIR) & Small Business Technology Transfer (STTR) programs) | Virginia Research Investment Fund (VRIF) | University Partnerships | Startup Company Mentoring & Engagement.

NEOGEN Partners with Hendrix Genetics to Improve Genetic Performance in Africa

Retrieved on: 
Tuesday, September 28, 2021
Food safety, Technology, Partnership, Animal, Food, Medium (website), Solution, Bird, NASDAQ, Income, Animal testing, Population, Genetic distance, Bill, Poultry, Drug, Environment, Knowledge, Disinfectant, Growth, Housing, Tropical climate, Genetics, Farmer, Genomics, Plant, Bill & Melinda Gates Foundation, Genotype, Global Health Innovative Technology Fund, Poverty, Agriculture

LINCOLN, Neb., Sept. 28, 2021 /PRNewswire/ --NEOGEN Corporation (NASDAQ: NEOG) announced today that they have partnered with Hendrix Genetics, a multi-species animal breeding, genetics, and technology company.

Key Points: 
  • LINCOLN, Neb., Sept. 28, 2021 /PRNewswire/ --NEOGEN Corporation (NASDAQ: NEOG) announced today that they have partnered with Hendrix Genetics, a multi-species animal breeding, genetics, and technology company.
  • Through this partnership, NEOGEN will support the implementation of genomic selection into Hendrix's Sustainable Access to Poultry Parent Stock in Africa (SAPPSA) program.
  • "We are pleased to join Hendrix Genetics in their mission to help secure the supply of high-quality parent stock to African smallholder farmers," said Marylinn Munson, Vice President of Genomics at NEOGEN.
  • "As Hendrix Genetics, we are very pleased with our partnership with NEOGEN in the SAPPSA project.